Korea sees first biopharma trade surplus in 6 years
South Korea recorded a trade surplus in biopharmaceutical products last year led by a sharp growth in Celltrion’s overseas sales, the Ministry of Food and Drug Safety said Monday. Korea’s biopharmaceutical exports rose 37.4 percent on-year to $892.4 million in 2015, while biopharma imports declined by 15.8 percent on-year to $738.22 million last year, according to the ministry data.
![[Translate to Coréen:]](http://aws-a.medias-ccifi.org/fileadmin/_processed_/4/1/csm_csm_IK1_4333_49d3696f42_6cac8402ff.jpg "[Translate to Coréen:]")
![[Translate to Coréen:]](http://aws-a.medias-ccifi.org/fileadmin/_processed_/0/7/csm_csm_Meta-Nature-Ai-Ddp-Seoul_credit-photo-nicolas-gaudelet__6__87fdd31871_e8848f7cf1.jpg "[Translate to Coréen:]")